BUSINESSglobal
Lilly Gets Lone Sell From HSBC Ahead of Deeper Weight Loss Drug Price Cuts
Single source
Updated 2 hours ago
First seen March 17, 2026 20:17:30Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
Eli Lilly & Co. shares tumbled after HSBC turned bearish on the stock, for the second time in a year, saying investor expectations for weight-loss drugs are overinflated.